|
gptkbp:instanceOf
|
gptkb:person
|
|
gptkbp:almaMater
|
gptkb:Princeton_University
gptkb:Johns_Hopkins_School_of_Medicine
|
|
gptkbp:awardReceived
|
gptkb:Breakthrough_Prize_in_Life_Sciences
gptkb:AACR_Richard_and_Hinda_Rosenthal_Memorial_Award
gptkb:Lasker-DeBakey_Clinical_Medical_Research_Award
gptkb:American_Cancer_Society_Medal_of_Honor
|
|
gptkbp:birthYear
|
1959
|
|
gptkbp:boardMemberOf
|
gptkb:Howard_Hughes_Medical_Institute
gptkb:Stand_Up_To_Cancer
|
|
gptkbp:employer
|
gptkb:Memorial_Sloan_Kettering_Cancer_Center
|
|
gptkbp:field
|
oncology
cancer biology
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Charles Sawyers
|
|
gptkbp:knownFor
|
development of targeted cancer therapies
research on chronic myeloid leukemia
|
|
gptkbp:memberOf
|
gptkb:American_Academy_of_Arts_and_Sciences
gptkb:National_Academy_of_Medicine
gptkb:National_Academy_of_Sciences
|
|
gptkbp:nationality
|
gptkb:American
|
|
gptkbp:notableWork
|
development of enzalutamide
development of imatinib (Gleevec)
|
|
gptkbp:occupation
|
gptkb:cancer
gptkb:physician
|
|
gptkbp:position
|
Chair, Human Oncology and Pathogenesis Program
|
|
gptkbp:bfsParent
|
gptkb:Lasker_Award
|
|
gptkbp:bfsLayer
|
4
|